NCT00961220 2018-05-22
O6-Benzylguanine and Topical Carmustine in Treating Patients With Early-Stage IA-IIA Cutaneous T-Cell Lymphoma
National Cancer Institute (NCI)
Phase 1/2 Completed
Clinical Trials
1 trialsHas results × Lymphoma, T-Cell, Cutaneous × carmustine, poliferprosan 20 drug combination × Clear all